Metraipolis › archive › dc_0bb5222addf3
A Prospective Clinical Trial of Efgartigimod for New-Onset Generalized Myasthenia Gravis — Europe PMC PMID:40776639
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40776639
- DOI
- 10.2174/011570159x366227250716054651
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T05:15:56.719Z
- SHA-256 of the archived text
170f3de28cf6c955950625b2d0cdf4170b6058f0fece407d2de9b84391e45e8f- Stable URL of this page
https://metraipolis.com/documento/dc_0bb5222addf3
How to cite
A Prospective Clinical Trial of Efgartigimod for New-Onset Generalized Myasthenia Gravis — Europe PMC PMID:40776639 — Europe PMC (en), https://europepmc.org/article/MED/40776639 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0bb5222addf3 (Metraipolis archive dc_0bb5222addf3, sha256 170f3de28cf6c955950625b2d0cdf4170b6058f0fece407d2de9b84391e45e8f)
BibTeX
@misc{dc0bb5222addf3,
title = {A Prospective Clinical Trial of Efgartigimod for New-Onset Generalized Myasthenia Gravis — Europe PMC PMID:40776639},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40776639},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0bb5222addf3; sha256 170f3de28cf6c955950625b2d0cdf4170b6058f0fece407d2de9b84391e45e8f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40776639. Agents can read the archived copy with the MCP tool read_document.